214 related articles for article (PubMed ID: 20437061)
1. Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport.
Kollewe K; Mohammadi B; Dengler R; Dressler D
J Neural Transm (Vienna); 2010 Jun; 117(6):759-63. PubMed ID: 20437061
[TBL] [Abstract][Full Text] [Related]
2. Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm.
Bentivoglio AR; Fasano A; Ialongo T; Soleti F; Lo Fermo S; Albanese A
Eur J Neurol; 2009 Mar; 16(3):392-8. PubMed ID: 19364366
[TBL] [Abstract][Full Text] [Related]
3. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
Badarny S; Susel Z; Honigman S
Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
[TBL] [Abstract][Full Text] [Related]
4. Routine use of Xeomin in patients previously treated with Botox: long term results.
Dressler D
Eur J Neurol; 2009 Dec; 16 Suppl 2():2-5. PubMed ID: 20002739
[TBL] [Abstract][Full Text] [Related]
5. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A--Dysport and Botox--assuming a ratio of 4:1.
Sampaio C; Ferreira JJ; Simões F; Rosas MJ; Magalhães M; Correia AP; Bastos-Lima A; Martins R; Castro-Caldas A
Mov Disord; 1997 Nov; 12(6):1013-8. PubMed ID: 9399229
[TBL] [Abstract][Full Text] [Related]
6. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
Bihari K
Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
[TBL] [Abstract][Full Text] [Related]
7. Long-term stable efficacy of botulinum toxin A in facial movement disorders with no need for increasing dose.
Badarny S; Ibrahim R; Susel Z; Zaina A; Nasar R; Badarny Y
Medicine (Baltimore); 2021 Jun; 100(25):e26481. PubMed ID: 34160460
[TBL] [Abstract][Full Text] [Related]
8. Synkinesis in primary and postparalytic hemifacial spasm: Clinical features and therapeutic outcomes of botulinum toxin A treatment.
Su JH; Yang MN; Teng F; Zhang XL; Pan YG; Hu Y; Xiao LB; Pan LZ; Li LX; Jin LJ
Toxicon; 2020 Sep; 184():122-126. PubMed ID: 32553733
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
Kongsengdao S; Kritalukkul S
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
[TBL] [Abstract][Full Text] [Related]
10. Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases.
Jitpimolmard S; Tiamkao S; Laopaiboon M
J Neurol Neurosurg Psychiatry; 1998 Jun; 64(6):751-7. PubMed ID: 9647304
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of blepharospasm, hemifacial spasm and facial synkinesis with botulinum toxin].
Winterhoff J; Laskawi R
HNO; 2012 Jun; 60(6):479-83. PubMed ID: 22669435
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years.
Sorgun MH; Yilmaz R; Akin YA; Mercan FN; Akbostanci MC
J Clin Neurosci; 2015 Aug; 22(8):1319-25. PubMed ID: 26100157
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm.
Pandey S; Jain S
Neurol India; 2018; 66(4):1036-1042. PubMed ID: 30038089
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
15. Dose conversion ratio, comparative efficacy, and adverse events after switching from onabotulinum toxin A to abobotulinum toxin A for neurological conditions.
Ozer IS; Kuzu Kumcu M; Tezcan Aydemir S; Akbostanci MC
Clin Neurol Neurosurg; 2021 Oct; 209():106889. PubMed ID: 34461363
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations.
Frei K; Truong DD; Dressler D
Eur J Neurol; 2006 Feb; 13 Suppl 1():30-5. PubMed ID: 16417595
[TBL] [Abstract][Full Text] [Related]
17. Complications of botulinum toxin application: differences between hemifacial spasm and post-facial palsy synkinesis.
Cakmak MA; Sahin S; Cinar N; Karsidag S
Acta Neurol Belg; 2014 Dec; 114(4):331. PubMed ID: 24647748
[No Abstract] [Full Text] [Related]
18. [Safety and efficacy of botulinum toxin in hemifacial spasm].
Mazlout H; Kamoun Gargouri H; Triki W; Kéfi S; Brour J; El Afrit MA; Chéour M; Kraiem A
J Fr Ophtalmol; 2013 Mar; 36(3):242-6. PubMed ID: 23270989
[TBL] [Abstract][Full Text] [Related]
19. Increasing the area and varying the dosage of Botulinum toxin a injections for effective treatment of hemifacial spasm.
Choe WJ; Kim J
Acta Otolaryngol; 2016 Sep; 136(9):952-5. PubMed ID: 27067535
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
Wu CJ; Shen JH; Chen Y; Lian YJ
Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
